Genetically altered and defined cell lines for transplantation in animal models of Parkinson's disease.
Freed
W J
WJ
NIMH Neurosciences Center, Washington, DC 20032.
Geller
H M
HM
Poltorak
M
M
Cannon-Spoor
H E
HE
Cottingham
S L
SL
LaMarca
M E
ME
Schultzberg
M
M
Rehavi
M
M
Paul
S
S
Ginns
E I
EI
D000310:Adrenal Gland Neoplasms / Q000473:pathology; D000818:Animals; D002478:Cells, Cultured / Q000637:transplantation*; D003342:Corpus Striatum; D004195:Disease Models, Animal; D005347:Fibroblasts / Q000201:enzymology / Q000637:transplantation; D015316:Genetic Therapy; D006801:Humans; D008546:Melanoma, Experimental / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D009414:Nerve Growth Factors / Q000494:pharmacology; D009857:Oncogenes; D010300:Parkinson Disease / Q000378:metabolism / Q000601:surgery*; D010673:Pheochromocytoma / Q000473:pathology; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D016042:Transplantation, Heterotopic; D014407:Tumor Cells, Cultured / Q000378:metabolism / Q000637:transplantation; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics / Q000378:metabolism
D009414:Nerve Growth Factors; D011993:Recombinant Fusion Proteins; D014446:Tyrosine 3-Monooxygenase